Search Results 921-930 of 13824 for Unipen

  1. Small bowel cancer - Doctors and departments - Mayo Clinic

    This type of cancer starts in the small intestine. Find out more about symptoms and treatments, including surgery, chemotherapy and targeted therapy.

  2. Meningioma - Doctors and departments - Mayo Clinic

    This is the most common type of tumor that forms in the head and may affect the brain. Find out about symptoms, diagnosis and treatment.

  3. Peripheral nerve tumors - Doctors and departments - Mayo Clinic

    Learn about these growths that form in or near nerves connecting to the spinal cord. Surgery is the most common treatment.

  4. Ependymoma - Doctors and departments - Mayo Clinic

    Learn about this tumor that forms from ependymal cells in the brain and spinal cord. Treatments include surgery, radiation therapy and chemotherapy.

  5. Peripheral nerve tumors - Doctors and departments - Mayo Clinic

    Learn about these growths that form in or near nerves connecting to the spinal cord. Surgery is the most common treatment.

  6. Peripheral nerve tumors - Doctors and departments - Mayo Clinic

    Learn about these growths that form in or near nerves connecting to the spinal cord. Surgery is the most common treatment.

  7. Medical Research & Education - Mayo Clinic News Network

    Latest stories · Could CAR-T cell therapy improve kidney transplants? · Mayo Clinic, Terasaki Institute launch collaboration for transplant innovation featured ...

  8. Peripheral nerve tumors - Doctors and departments - Mayo Clinic

    Learn about these growths that form in or near nerves connecting to the spinal cord. Surgery is the most common treatment.

  9. Ependymoma - Doctors and departments - Mayo Clinic

    Learn about this tumor that forms from ependymal cells in the brain and spinal cord. Treatments include surgery, radiation therapy and chemotherapy.

  10. Clinical trials - Oncology (Medical)

    Rochester, Minn. This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia ...